Cargando…
Identifying potential pharmacological targets and mechanisms of vitamin D for hepatocellular carcinoma and COVID-19
Coronavirus disease 2019 (COVID‐19) is a severe pandemic that has posed an unprecedented challenge to public health worldwide. Hepatocellular carcinoma (HCC) is a common digestive system malignancy, with high aggressiveness and poor prognosis. HCC patients may be vulnerable to COVID-19. Since the an...
Autores principales: | Huang, Yongbiao, Yuan, Ye, Chen, Sheng, Xu, Duo, Xiao, Lingyan, Wang, Xi, Qin, Wan, Liu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583923/ https://www.ncbi.nlm.nih.gov/pubmed/36275701 http://dx.doi.org/10.3389/fimmu.2022.985781 |
Ejemplares similares
-
Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2021) -
Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy
por: Huang, Yongbiao, et al.
Publicado: (2022) -
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential
por: Han, Qin, et al.
Publicado: (2022) -
A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020) -
Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential
por: Dankers, Wendy, et al.
Publicado: (2017)